4/8
05:20 pm
eigr
Form 10-K Eiger BioPharmaceuticals For: Dec 31
High
Report
Form 10-K Eiger BioPharmaceuticals For: Dec 31
4/3
04:45 pm
eigr
Form 8-K Eiger BioPharmaceuticals For: Apr 01
High
Report
Form 8-K Eiger BioPharmaceuticals For: Apr 01
4/1
05:01 pm
eigr
Form NT 10-K Eiger BioPharmaceuticals For: Dec 31
Low
Report
Form NT 10-K Eiger BioPharmaceuticals For: Dec 31
4/1
04:59 pm
eigr
Form S-8 POS Eiger BioPharmaceuticals
Medium
Report
Form S-8 POS Eiger BioPharmaceuticals
4/1
04:57 pm
eigr
Form S-8 POS Eiger BioPharmaceuticals
Medium
Report
Form S-8 POS Eiger BioPharmaceuticals
4/1
04:56 pm
eigr
Form S-8 POS Eiger BioPharmaceuticals
Medium
Report
Form S-8 POS Eiger BioPharmaceuticals
4/1
04:55 pm
eigr
Form S-8 POS Eiger BioPharmaceuticals
Low
Report
Form S-8 POS Eiger BioPharmaceuticals
4/1
04:54 pm
eigr
Form S-8 POS Eiger BioPharmaceuticals
Low
Report
Form S-8 POS Eiger BioPharmaceuticals
4/1
04:52 pm
eigr
Form S-8 POS Eiger BioPharmaceuticals
Medium
Report
Form S-8 POS Eiger BioPharmaceuticals
4/1
04:51 pm
eigr
Form S-8 POS Eiger BioPharmaceuticals
Medium
Report
Form S-8 POS Eiger BioPharmaceuticals
4/1
04:49 pm
eigr
Form S-8 POS Eiger BioPharmaceuticals
Medium
Report
Form S-8 POS Eiger BioPharmaceuticals
4/1
04:49 pm
eigr
Form S-8 POS Eiger BioPharmaceuticals
Medium
Report
Form S-8 POS Eiger BioPharmaceuticals
4/1
04:46 pm
eigr
Form S-8 POS Eiger BioPharmaceuticals
Low
Report
Form S-8 POS Eiger BioPharmaceuticals
4/1
04:46 pm
eigr
Form S-8 POS Eiger BioPharmaceuticals
Low
Report
Form S-8 POS Eiger BioPharmaceuticals
4/1
04:18 pm
eigr
Form 8-K Eiger BioPharmaceuticals For: Mar 31
Low
Report
Form 8-K Eiger BioPharmaceuticals For: Mar 31
3/11
04:03 pm
eigr
Form 8-K Eiger BioPharmaceuticals For: Mar 08
High
Report
Form 8-K Eiger BioPharmaceuticals For: Mar 08
2/14
04:06 pm
eigr
Form SC 13G/A Eiger BioPharmaceuticals Filed by: 683 Capital Management, LLC
Low
Report
Form SC 13G/A Eiger BioPharmaceuticals Filed by: 683 Capital Management, LLC
2/14
10:56 am
eigr
Form SC 13G/A Eiger BioPharmaceuticals Filed by: AMERIPRISE FINANCIAL INC
Neutral
Report
Form SC 13G/A Eiger BioPharmaceuticals Filed by: AMERIPRISE FINANCIAL INC